Mercer S L, Goel V, Levy I G, Ashbury F D, Iverson D C, Iscoe N A
Institute for Clinical Evaluative Sciences in Ontario.
Can J Public Health. 1997 Sep-Oct;88(5):327-32. doi: 10.1007/BF03403900.
Despite controversy about prostate cancer screening, administrative data show that the use of prostate specific antigen (PSA) testing in Canada has increased. This study sought to determine awareness and knowledge of prostate cancer and screening, use to date, and future intentions to have a digital rectal examination (DRE) and PSA test among Canadian men aged 40 and over. Data were collected through a Canada-wide cross-sectional random digit dial telephone survey of 629 men. Awareness of DRE and PSA, use to date, and future intended use varied with age and education. Although only 9% of respondents had had PSA testing for screening, future intentions to undergo this test were higher than use to date. Knowledge of prostate cancer and screening controversies was low, and men received more information about PSA from the media than from doctors. Men would, therefore, benefit from age- and education-specific information regarding the factors to consider in making an informed choice about prostate cancer screening.
尽管前列腺癌筛查存在争议,但行政数据显示,加拿大前列腺特异性抗原(PSA)检测的使用有所增加。本研究旨在确定40岁及以上加拿大男性对前列腺癌及其筛查的知晓情况和知识水平、目前的使用情况,以及未来进行直肠指检(DRE)和PSA检测的意向。数据通过对629名男性进行的全加拿大横断面随机数字拨号电话调查收集。对DRE和PSA的知晓情况、目前的使用情况以及未来的使用意向随年龄和教育程度而有所不同。尽管只有9%的受访者进行过PSA筛查检测,但未来进行该项检测的意向高于目前的使用情况。对前列腺癌及其筛查争议的了解程度较低,男性从媒体获得的关于PSA的信息多于从医生那里获得的信息。因此,男性将受益于针对年龄和教育程度的特定信息,这些信息涉及在对前列腺癌筛查做出明智选择时需要考虑的因素。